(Q30799242)

26 June 2017

1 reference

title

Biological predictors of treatment response in affective illness (English)

1 reference

26 June 2017

3

Perry F Renshaw

1 reference

26 June 2017

1

Roy H Perlis

1 reference

26 June 2017

Dan V Iosifescu

2

1 reference

26 June 2017

publication date

1 June 2003

1 reference

Psychiatric Clinics of North America

26 June 2017

published in

1 reference

26 June 2017

volume

26

1 reference

26 June 2017

issue

2

1 reference

26 June 2017

page(s)

323-44, vii

1 reference

Definition and epidemiology of treatment-resistant depression

26 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

Norepinephrine output and metabolism in depressed patients during antidepressant treatments

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

Monoamine neurotransmitter interactions and the prediction of antidepressant response

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

The DST as a predictor of outcome in depression: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

DST abnormality as a predictor of course in major depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

Basal plasma dehydroepiandrosterone sulfate level: a possible predictor for response to electroconvulsive therapy in depressed psychotic inpatients.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

Testosterone, androstenedione and dihydrotestosterone concentrations are elevated in female patients with major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

Relationships of dehydroepiandrosterone sulfate in the elderly with functional, psychological, and mental status, and short-term mortality: a French community-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

DHEA-S levels and depressive symptoms in a cohort of African American and Caucasian women in the late reproductive years

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

Predictors of response to lithium augmentation in tricyclic antidepressant-resistant depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

Predicting outcome of lithium added to antidepressants in resistant depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

Slower treatment response in bipolar depression predicted by lower pretreatment thyroid function

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

Peripheral thyroid hormone levels in treatment resistant depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

T3 blood levels and treatment outcome in depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

TSH-response patterns to TRH stimulation may indicate therapeutic mechanisms of antidepressant and neuroleptic drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

The thyrotropin response to thyrotropin-releasing hormone as a predictor of response to treatment in depressed outpatients

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

Altered serum levels of thyroxine, triiodothyronines and diiodothyronines in endogenous depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

Prediction of relapse with the TRH test and prophylactic amitriptyline in 39 patients with endogenous depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

TRH stimulation test as a predictor of acute and long-term antidepressant response in major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

Plasma prolactin changes following fenfluramine in depressed patients compared to controls: an evaluation of central serotonergic responsivity in depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

Serotonergic stimulation of prolactin and corticosterone secretion is mediated by different pathways from the mediobasal hypothalamus.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

Prolactin and cortisol responses to d-fenfluramine in major depression: evidence for diminished responsivity of central serotonergic function

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

Reduced prolactin and cortisol responses to d-fenfluramine in depressed compared to healthy matched control subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

Do the endocrine and subjective effects of d-fenfluramine predict response to selective serotonin reuptake inhibitors?

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

Assessment of serotonergic function in major depression using d-fenfluramine: relation to clinical variables and antidepressant response

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

Serotonin and the prediction of response time to fluoxetine in patients with mild depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

Prolactin response to d-fenfluramine in obsessive-compulsive patients, and outcome of fluvoxamine treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

Serotonin function and antiaggressive response to fluoxetine: a pilot study.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

The loudness dependency of the auditory evoked N1/P2-component as a predictor of the acute SSRI response in depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

Auditory evoked potential modifications according to clinical and biochemical responsiveness to fenfluramine treatment in children with autistic behavior.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

Loudness dependence of auditory evoked potentials in obsessive–compulsive disorder: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

Intensity dependence of auditory evoked potentials and clinical response to prophylactic lithium medication: A replication study

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

Prevalence and significance of electroencephalographic abnormalities in patients with suspected organic mental syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

The ictal EEG as a marker of adequate stimulus intensity with unilateral ECT

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

Quantitative EEG during seizures induced by electroconvulsive therapy: relations to treatment modality and clinical features. I. Global analyses.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

Post-seizure EEG fractal dimension of first ECT predicts antidepressant response at two weeks.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

Is postictal electrical silence a predictor of response to electroconvulsive therapy?

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

Acute vs. chronic EEG effects in maprotiline- and in clomipramine-treated depressive inpatients and the prediction of therapeutic outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

Quantitative EEG in the prediction of antidepressant response to imipramine.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

Altered cerebral energy utilization in late life depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

Neurophysiologic predictors of treatment response to fluoxetine in major depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

Prefrontal changes and treatment response prediction in depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

Anterior cingulate activity as a predictor of degree of treatment response in major depression: evidence from brain electrical tomography analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

Structural abnormalities in brain magnetic resonance images of depressed children.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

Late-onset minor and major depression: early evidence for common neuroanatomical substrates detected by using MRI

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

Subgenual prefrontal cortex abnormalities in mood disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

Hippocampal atrophy in recurrent major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

Hippocampal volume reduction in major depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

Magnetic-resonance morphometry in patients with major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

Amygdala core nuclei volumes are decreased in recurrent major depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

Hippocampus and amygdala pathology in depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

Atrophy and high intensity lesions: complementary neurobiological mechanisms in late-life major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

White matter hyperintensities and gray matter lesions in physically healthy depressed subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

Incidental lesions noted on magnetic resonance imaging of the brain: prevalence and clinical significance in various age groups

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

The prevalence and severity of white matter lesions, their relationship with age, ethnicity, gender, and cardiovascular disease risk factors: the ARIC Study

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

White matter signal abnormalities in normal individuals: correlation with carotid ultrasonography, cerebral blood flow measurements, and cerebrovascular risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

Subcortical hyperintensities on magnetic resonance imaging: Clinical correlates and prognostic significance in patients with severe depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

1997 IPA/Bayer Research Awards in Psychogeriatrics. Subcortical hyperintensities in late-life depression: acute response to treatment and neuropsychological impairment.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

Is subcortical disease associated with a poor response to antidepressants? Neurological, neuropsychological and neuroradiological findings in late-life depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

Six-month outcomes for MRI-related vascular depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

MRI findings in patients with affective disorder: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

MRI signal hyperintensities in geriatric depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

Cerebrovascular disease and depression symptoms in the cardiovascular health study

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

Neuroimaging in bipolar disorder: what have we learned?

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

T2 hyperintensities in bipolar disorder: magnetic resonance imaging comparison and literature meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

Cardiovascular risk factors in affective disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

Structural brain abnormalities in first-episode mania

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

Magnetic resonance spectroscopy: current and future applications in psychiatric research

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

Variability of brain lithium levels during maintenance treatment: a magnetic resonance spectroscopy study

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

Brain kinetics of paroxetine and fluoxetine on the third day of placebo substitution: a fluorine MRS study

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

19F magnetic resonance spectroscopy investigation in vivo of acute and steady-state brain fluvoxamine levels in obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

Basal ganglia choline levels in depression and response to fluoxetine treatment: an in vivo proton magnetic resonance spectroscopy study.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

Compounds containing cytosolic choline in the basal ganglia: a potential biological marker of true drug response to fluoxetine

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

Increased orbitofrontal cortex levels of choline in depressed adolescents as detected by in vivo proton magnetic resonance spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

Myo-inositol in depressive and healthy subjects determined by frontal 1H-magnetic resonance spectroscopy at 1.5 tesla.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

Proton magnetic resonance spectroscopy of the lenticular nuclei in bipolar I affective disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

Decreased dorsolateral prefrontal N-acetyl aspartate in bipolar disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

Lower levels of nucleoside triphosphate in the basal ganglia of depressed subjects: a phosphorous-31 magnetic resonance spectroscopy study.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

31P magnetic resonance spectroscopy in the frontal lobe of major depressed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

Brain phosphorous metabolism in depressive disorders detected by phosphorus-31 magnetic resonance spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

Reduction of brain phosphocreatine in bipolar II disorder detected by phosphorus-31 magnetic resonance spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

Multinuclear magnetic resonance spectroscopy studies of brain purines in major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

Single photon emission tomography with 99mTc-exametazime in major depression and the pattern of brain activity underlying the psychotic/neurotic continuum.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

Frontal cerebral perfusion dysfunction in elderly late-onset major depression assessed by 99MTC-HMPAO SPECT

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

Changes in regional brain glucose metabolism measured with positron emission tomography after paroxetine treatment of major depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

Regional brain metabolic changes in patients with major depression treated with either paroxetine or interpersonal therapy: preliminary findings

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

Limbic-cortical dysregulation: a proposed model of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

Effects of sleep deprivation on the limbic system and the frontal lobes in affective disorders: a study with Tc-99m-HMPAO SPECT.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

Effect of sleep deprivation on brain metabolism of depressed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

Preliminary Data on the Metabolic Brain Pattern of Patients With Winter Seasonal Affective Disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

PET measurements of brain glucose metabolism and blood flow in major depressive disorder: a critical review

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

Reduction of prefrontal cortex glucose metabolism common to three types of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

Regional cerebral glucose metabolism in major depressive disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

Left prefrontal glucose hypometabolism in the depressed state: a confirmation.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

Effect of sertraline on regional metabolic rate in patients with affective disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

Cingulate function in depression: a potential predictor of treatment response.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

Brain metabolic changes in major depressive disorder from pre- to post-treatment with paroxetine

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

Differential cerebral metabolic changes with paroxetine treatment of obsessive-compulsive disorder vs major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

The functional neuroanatomy of the placebo effect

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

Positron emission tomography measurement of cerebral metabolic correlates of tryptophan depletion-induced depressive relapse.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

In vivo evidence for the involvement of dopamine-D2 receptors in striatum and anterior cingulate gyrus in major depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900112-0

7 January 2021

10.1016/S0193-953X(02)00112-0

Identifiers

DOI

1 reference

26 June 2017

1 reference